NEW YORK (GenomeWeb) – French molecular diagnostics firm Genomic Vision announced today that it has been selected to participate in BeyondSeq, an EU-funded alliance of industry and academic groups developing new optical DNA mapping technologies for diagnostic applications.

BeyondSeq — short for Genomic Diagnostics Beyond the Sequence — kicked off last month and is funded through May 2019 with €6 million from the EU's Horizon 2020 research and innovation program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.

Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.

Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.

In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.